We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$17.7B
AUM Growth
+$2.98B
(+20%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,173
New
33
Increased
727
Reduced
328
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$505M |
| 2 |
Intel
INTC
|
+$122M |
| 3 |
Apple
AAPL
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$98.1M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$90.1M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$37.3M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$32.8M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$15.9M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.79% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 4.29% |
| 5 | Energy | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Crown Castle
CCI
$33.4B
| $5.26M | 0.03% |
46,158
+657
| +1% | +$78.2K |
|
|
VERV
402
DELISTED
Verve Therapeutics
VERV
| $5.25M | 0.03% |
279,918
+16,880
| +6% | +$281K |
|
403
FedEx
FDX
$73B
| $5.23M | 0.03% |
21,104
+1,712
| +9% | +$392K |
|
404
Targa Resources
TRGP
$57.6B
| $5.2M | 0.03% |
68,336
+207
| +0.3% | +$15K |
|
405
Brown & Brown
BRO
$23.7B
| $5.2M | 0.03% |
75,526
-3,681
| -5% | -$234K |
|
|
CADE
406
DELISTED
Cadence Bank
CADE
| $5.16M | 0.03% |
262,516
+97,538
| +59% | +$1.92M |
|
|
AXON
407
Axon Enterprise
AXON
$42.3B
| $5.11M | 0.03% |
26,199
+3,350
| +15% | +$694K |
|
408
Synchrony
SYF
$25.1B
| $5.1M | 0.03% |
150,450
-10,241
| -6% | -$313K |
|
409
Textron
TXT
$15B
| $5.1M | 0.03% |
75,345
-8,849
| -11% | -$584K |
|
410
Ford
F
$59.3B
| $5.02M | 0.03% |
331,899
+35,154
| +12% | +$445K |
|
411
Illinois Tool Works
ITW
$81.6B
| $5.01M | 0.03% |
20,037
+1,923
| +11% | +$450K |
|
|
BLD
412
DELISTED
TopBuild
BLD
| $5M | 0.03% |
18,788
-157
| -0.8% | -$34.5K |
|
413
Northern Trust
NTRS
$22.4B
| $4.96M | 0.03% |
66,902
-3,364
| -5% | -$258K |
|
414
Factset
FDS
$9.35B
| $4.95M | 0.03% |
12,356
-539
| -4% | -$217K |
|
415
Kymera Therapeutics
KYMR
$8.8B
| $4.93M | 0.03% |
214,490
+5,401
| +3% | +$155K |
|
416
Texas Capital Bancshares
TCBI
$4.29B
| $4.92M | 0.03% |
95,623
+46,919
| +96% | +$2.34M |
|
417
Public Storage
PSA
$59.3B
| $4.91M | 0.03% |
16,837
+221
| +1% | +$64.4K |
|
418
Cincinnati Financial
CINF
$26.8B
| $4.91M | 0.03% |
50,488
-2,513
| -5% | -$260K |
|
419
Bankunited
BKU
$3.33B
| $4.88M | 0.03% |
226,468
+120,661
| +114% | +$2.48M |
|
420
MannKind Corp
MNKD
$1.27B
| $4.82M | 0.03% |
1,184,355
-198,515
| -14% | -$828K |
|
421
Toll Brothers
TOL
$14B
| $4.82M | 0.03% |
60,941
+10
| +0% | +$671 |
|
422
Zebra Technologies
ZBRA
$13.7B
| $4.81M | 0.03% |
16,253
+3,425
| +27% | +$961K |
|
423
Immunovant
IMVT
$8.11B
| $4.77M | 0.03% |
251,621
-76,295
| -23% | -$1.42M |
|
424
Norfolk Southern
NSC
$75B
| $4.76M | 0.03% |
21,012
+2,023
| +11% | +$430K |
|
425
Arcutis Biotherapeutics
ARQT
$3.5B
| $4.76M | 0.03% |
499,922
+195,216
| +64% | +$2.17M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Rafferty Asset Management held 1,173 positions worth $17.7B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q2 2023, opening 33 new positions and adding to 727 existing holdings. Its largest new stake was Biomea Fusion: 136,903 shares worth $3.01M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $90.1M trimmed.
- Rafferty Asset Management's largest Q2 2023 buy was Biomea Fusion: 136,903 shares worth $3.01M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2023, an estimated $505M increase.
- Rafferty Asset Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $90.1M.
- Rafferty Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $6.38M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $17.7B portfolio in Q2 2023.
- Rafferty Asset Management opened 33 new positions and closed 84 in Q2 2023.
- Rafferty Asset Management's portfolio value rose 20% quarter-over-quarter to $17.7B.
Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.